ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances
Source: SeekingAlpha
2025-11-19 17:04:21 ET
More on ProPhase Labs
- ProPhase Labs, Inc. (PRPH) Q3 2025 Earnings Call Transcript
- ProPhase Labs, Inc. 2025 Q3 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on ProPhase Labs
- Financial information for ProPhase Labs
Read the full article on Seeking Alpha
For further details see:
ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances
ProPhase Labs Inc.
NASDAQ: PRPH
PRPH Trading
-15.95% G/L:
$0.43 Last:
211,534 Volume:
$0.4641 Open:
PRPH Latest News
February 03, 2026 07:00:00 am
ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart(TM) and Advances Crown Medical Collections Initiative
February 02, 2026 08:00:00 am
Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on February 3rd
PRPH Stock Data
$732,464
3,785,863
2.93%
8
289006%
Medical Diagnostics & Screening
Healthcare
US
Uniondale
